ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global (United States, European Union and China) Anti-Obesity Therapeutics Market Research Report 2019-2025
Published Date: 2019-10-15
|
Report Code: QYRE-Auto-26N204
Home | Market Reports
Global United States European Union and China Anti Obesity Therapeutics Market Research Report 2019 2025

Global (United States, European Union and China) Anti-Obesity Therapeutics Market Research Report 2019-2025

Code: QYRE-Auto-26N204
Report
2019-10-15
Pages:119
QYResearch
Description
Table of Content
Tables & Figures

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.

Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

In 2019, the market size of Anti-Obesity Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Obesity Therapeutics. 

This report studies the global market size of Anti-Obesity Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Anti-Obesity Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

  • Bristol-Myers Squibb
  • Eisai Company
  • FlaxoSithKline plc.
  • Novo Nordisk
  • Alizyme
  • BoehringerIngelheim GmbH
  • Pfizer
  • Takeda Pharmaceutical
  • Rhythm Pharmaceuticals
  • Shionogi USA
  • Vivus
  • Zafgen
  • Norgine Pharmaceuticals Ltd. 

Market Segment by Product Type

  • Centrally Acting Anti-obesity Drugs
  • Peripherally Acting Anti-obesity Drugs 

Market Segment by Application

  • Hospital Use
  • Clinic Use
  • Household
  • Other 

Key Regions split in this report: breakdown data for each region.

  • United States
  • China
  • European Union
  • Rest of World (Japan, Korea, India and Southeast Asia)
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Obesity Therapeutics Market Size Growth Rate by Type (2019-2025)
1.3.2 Centrally Acting Anti-obesity Drugs
1.3.3 Peripherally Acting Anti-obesity Drugs
1.4 Market Segment by Application
1.4.1 Global Anti-Obesity Therapeutics Market Share by Application (2019-2025)
1.4.2 Hospital Use
1.4.3 Clinic Use
1.4.4 Household
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Obesity Therapeutics Market Size
2.1.1 Global Anti-Obesity Therapeutics Revenue 2014-2025
2.1.2 Global Anti-Obesity Therapeutics Sales 2014-2025
2.2 Anti-Obesity Therapeutics Growth Rate by Regions
2.2.1 Global Anti-Obesity Therapeutics Sales by Regions 2014-2019
2.2.2 Global Anti-Obesity Therapeutics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Obesity Therapeutics Sales by Manufacturers
3.1.1 Anti-Obesity Therapeutics Sales by Manufacturers 2014-2019
3.1.2 Anti-Obesity Therapeutics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Obesity Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Obesity Therapeutics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-Obesity Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Obesity Therapeutics Price by Manufacturers
3.4 Key Manufacturers Anti-Obesity Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Obesity Therapeutics Market
3.6 Key Manufacturers Anti-Obesity Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Centrally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.1.2 Peripherally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.2 Global Anti-Obesity Therapeutics Sales Market Share by Type
4.3 Global Anti-Obesity Therapeutics Revenue Market Share by Type
4.4 Anti-Obesity Therapeutics Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Obesity Therapeutics Sales by Application
6 United States
6.1 United States Anti-Obesity Therapeutics Breakdown Data by Company
6.2 United States Anti-Obesity Therapeutics Breakdown Data by Type
6.3 United States Anti-Obesity Therapeutics Breakdown Data by Application
7 European Union
7.1 European Union Anti-Obesity Therapeutics Breakdown Data by Company
7.2 European Union Anti-Obesity Therapeutics Breakdown Data by Type
7.3 European Union Anti-Obesity Therapeutics Breakdown Data by Application
8 China
8.1 China Anti-Obesity Therapeutics Breakdown Data by Company
8.2 China Anti-Obesity Therapeutics Breakdown Data by Type
8.3 China Anti-Obesity Therapeutics Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Obesity Therapeutics Breakdown Data by Company
9.2 Rest of World Anti-Obesity Therapeutics Breakdown Data by Type
9.3 Rest of World Anti-Obesity Therapeutics Breakdown Data by Application
9.4 Rest of World Anti-Obesity Therapeutics Breakdown Data by Countries
9.4.1 Rest of World Anti-Obesity Therapeutics Sales by Countries
9.4.2 Rest of World Anti-Obesity Therapeutics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.1.4 Anti-Obesity Therapeutics Product Introduction
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Eisai Company
10.2.1 Eisai Company Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.2.4 Anti-Obesity Therapeutics Product Introduction
10.2.5 Eisai Company Recent Development
10.3 FlaxoSithKline plc.
10.3.1 FlaxoSithKline plc. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.3.4 Anti-Obesity Therapeutics Product Introduction
10.3.5 FlaxoSithKline plc. Recent Development
10.4 Novo Nordisk
10.4.1 Novo Nordisk Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.4.4 Anti-Obesity Therapeutics Product Introduction
10.4.5 Novo Nordisk Recent Development
10.5 Alizyme
10.5.1 Alizyme Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.5.4 Anti-Obesity Therapeutics Product Introduction
10.5.5 Alizyme Recent Development
10.6 BoehringerIngelheim GmbH
10.6.1 BoehringerIngelheim GmbH Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.6.4 Anti-Obesity Therapeutics Product Introduction
10.6.5 BoehringerIngelheim GmbH Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.7.4 Anti-Obesity Therapeutics Product Introduction
10.7.5 Pfizer Recent Development
10.8 Takeda Pharmaceutical
10.8.1 Takeda Pharmaceutical Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.8.4 Anti-Obesity Therapeutics Product Introduction
10.8.5 Takeda Pharmaceutical Recent Development
10.9 Rhythm Pharmaceuticals
10.9.1 Rhythm Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.9.4 Anti-Obesity Therapeutics Product Introduction
10.9.5 Rhythm Pharmaceuticals Recent Development
10.10 Shionogi USA
10.10.1 Shionogi USA Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-Obesity Therapeutics
10.10.4 Anti-Obesity Therapeutics Product Introduction
10.10.5 Shionogi USA Recent Development
10.11 Vivus
10.12 Zafgen
10.13 Norgine Pharmaceuticals Ltd.
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Obesity Therapeutics Sales Channels
11.2.2 Anti-Obesity Therapeutics Distributors
11.3 Anti-Obesity Therapeutics Customers
12 Market Forecast
12.1 Global Anti-Obesity Therapeutics Sales and Revenue Forecast 2019-2025
12.2 Global Anti-Obesity Therapeutics Sales Forecast by Type
12.3 Global Anti-Obesity Therapeutics Sales Forecast by Application
12.4 Anti-Obesity Therapeutics Forecast by Regions
12.4.1 Global Anti-Obesity Therapeutics Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-Obesity Therapeutics Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
    Figure Anti-Obesity Therapeutics Product Picture
    Table Anti-Obesity Therapeutics Key Market Segments
    Table Major Manufacturers Anti-Obesity Therapeutics Covered in This Report
    Table Global Anti-Obesity Therapeutics Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
    Figure Global Anti-Obesity Therapeutics Sales Market Shar by Type 2014-2025
    Figure Centrally Acting Anti-obesity Drugs Figures
    Table Major Manufacturers of Centrally Acting Anti-obesity Drugs
    Figure Peripherally Acting Anti-obesity Drugs Figures
    Table Major Manufacturers of Peripherally Acting Anti-obesity Drugs
    Table Global Anti-Obesity Therapeutics Market Share by Application 2019-2025 (K Units)
    Figure Hospital Use Use Case
    Figure Clinic Use Use Case
    Figure Household Use Case
    Figure Other Use Case
    Figure Anti-Obesity Therapeutics Report Years Considered
    Figure Global Anti-Obesity Therapeutics Market Size 2014-2025 (Million US$)
    Figure Global Anti-Obesity Therapeutics Sales 2014-2019 (K Units)
    Table Global Anti-Obesity Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Anti-Obesity Therapeutics Sales by Regions 2014-2019 (K Units)
    Table Global Anti-Obesity Therapeutics Sales Market Share by Regions 2014-2019
    Figure Global Anti-Obesity Therapeutics Sales Market Share by Regions 2014-2019
    Figure Global Anti-Obesity Therapeutics Sales Market Share by Regions in 2019
    Table Global Anti-Obesity Therapeutics Revenue by Regions 2014-2019 (Million US$)
    Table Global Anti-Obesity Therapeutics Revenue Market Share by Regions 2014-2019
    Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions 2014-2019
    Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2019
    Table Market Top Trends
    Table Global Anti-Obesity Therapeutics Sales by Manufacturers (2014-2019) (K Units)
    Table Global Anti-Obesity Therapeutics Sales Share by Manufacturers (2014-2019)
    Figure Global Anti-Obesity Therapeutics Sales Share by Manufacturers in 2019
    Table Anti-Obesity Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
    Table Anti-Obesity Therapeutics Revenue Share by Manufacturers (2014-2019)
    Figure Anti-Obesity Therapeutics Value Share by Manufacturers in 2019
    Table Global Anti-Obesity Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Anti-Obesity Therapeutics Price (2014-2019) (USD/Unit)
    Table Key Manufacturers Anti-Obesity Therapeutics Plants/Factories Distribution
    Table Key Manufacturers Anti-Obesity Therapeutics Area Served
    Table Date of Key Manufacturers Enter into Anti-Obesity Therapeutics Market
    Table Key Manufacturers Anti-Obesity Therapeutics Product Type
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Centrally Acting Anti-obesity Drugs Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Peripherally Acting Anti-obesity Drugs Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Anti-Obesity Therapeutics Sales by Type (2014-2019) (K Units)
    Table Global Anti-Obesity Therapeutics Sales Share by Type (2014-2019)
    Figure Global Anti-Obesity Therapeutics Sales Market Share by Type (2014-2019)
    Figure Global Anti-Obesity Therapeutics Sales Market Share by Type in 2018
    Table Global Anti-Obesity Therapeutics Revenue by Type (2014-2019) (Million US$)
    Table Global Anti-Obesity Therapeutics Revenue Share by Type (2014-2019)
    Figure Global Anti-Obesity Therapeutics Revenue Market Share by Type (2014-2019)
    Figure Global Anti-Obesity Therapeutics Revenue Market Share by Type in 2018
    Table Anti-Obesity Therapeutics Price by Type 2014-2019 (USD/Unit)
    Table Global Anti-Obesity Therapeutics Sales by Application (2014-2019) (K Units)
    Table Global Anti-Obesity Therapeutics Sales Share by Application (2014-2019)
    Figure Global Sales Anti-Obesity Therapeutics Market Share by Application (2014-2019)
    Figure Global Sales Anti-Obesity Therapeutics Market Share by Application (2014-2019)
    Figure United States Anti-Obesity Therapeutics Sales Growth Rate 2014-2019 (K Units)
    Figure United States Anti-Obesity Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
    Table United States Anti-Obesity Therapeutics Sales by Company (2014-2019) (K Units)
    Table United States Anti-Obesity Therapeutics Sales Market Share by Company (2014-2019)
    Figure United States Anti-Obesity Therapeutics Sales Market Share by Company in 2019
    Table United States Anti-Obesity Therapeutics Sales by Type (2014-2019) (K Units)
    Table United States Anti-Obesity Therapeutics Sales Market Share by Type (2014-2019)
    Figure United States Anti-Obesity Therapeutics Market Share by Type in 2019
    Table United States Anti-Obesity Therapeutics Sales by Application (2014-2019) (K Units)
    Table United States Anti-Obesity Therapeutics Sales Market Share by Application (2014-2019)
    Figure United States Anti-Obesity Therapeutics Market Share by Application in 2019
    Figure European Union Anti-Obesity Therapeutics Sales Growth Rate 2014-2019 (K Units)
    Figure European Union Anti-Obesity Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
    Table European Union Anti-Obesity Therapeutics Sales by Company (2014-2019) (K Units)
    Table European Union Anti-Obesity Therapeutics Sales Market Share by Company (2014-2019)
    Figure European Union Anti-Obesity Therapeutics Sales Market Share by Company in 2019
    Table European Union Anti-Obesity Therapeutics Sales by Type (2014-2019) (K Units)
    Table European Union Anti-Obesity Therapeutics Sales Market Share by Type (2014-2019)
    Figure 2018 European Union Anti-Obesity Therapeutics Market Share by Type
    Table European Union Anti-Obesity Therapeutics Sales by Application (2014-2019) (K Units)
    Table European Union Anti-Obesity Therapeutics Sales Market Share by Application (2014-2019)
    Figure 2018 European Union Anti-Obesity Therapeutics Market Share by Application
    Figure China Anti-Obesity Therapeutics Sales Growth Rate 2014-2019 (K Units)
    Figure China Anti-Obesity Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
    Table China Anti-Obesity Therapeutics Sales by Company (2014-2019) (K Units)
    Table China Anti-Obesity Therapeutics Sales Market Share by Company (2014-2019)
    Figure China Anti-Obesity Therapeutics Sales Market Share by Company in 2019
    Table China Anti-Obesity Therapeutics Sales by Type (2014-2019) (K Units)
    Table China Anti-Obesity Therapeutics Sales Market Share by Type (2014-2019)
    Figure China Anti-Obesity Therapeutics Market Share by Type in 2019
    Table China Anti-Obesity Therapeutics Sales by Application (2014-2019) (K Units)
    Table China Anti-Obesity Therapeutics Sales Market Share by Application (2014-2019)
    Figure China Anti-Obesity Therapeutics Market Share by Application in 2019
    Figure Rest of World Anti-Obesity Therapeutics Sales Growth Rate 2014-2019 (K Units)
    Figure Rest of World Anti-Obesity Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
    Table Rest of World Anti-Obesity Therapeutics Sales by Company (2014-2019) (K Units)
    Table Rest of World Anti-Obesity Therapeutics Sales Market Share by Company (2014-2019)
    Figure Rest of World Anti-Obesity Therapeutics Sales Market Share by Company in 2019
    Table Rest of World Anti-Obesity Therapeutics Sales by Type (2014-2019) (K Units)
    Table Rest of World Anti-Obesity Therapeutics Sales Market Share by Type (2014-2019)
    Figure Rest of World Anti-Obesity Therapeutics Market Share by Type in 2019
    Table Rest of World Anti-Obesity Therapeutics Sales by Application (2014-2019) (K Units)
    Table Rest of World Anti-Obesity Therapeutics Sales Market Share by Application (2014-2019)
    Figure Rest of World Anti-Obesity Therapeutics Market Share by Application in 2019
    Table Rest of World Anti-Obesity Therapeutics Sales by Countries (2014-2019) (K Units)
    Table Rest of World Anti-Obesity Therapeutics Sales Market Share by Countries (2014-2019)
    Figure Rest of World Anti-Obesity Therapeutics Sales Market Share by Countries in 2019
    Table Rest of World Anti-Obesity Therapeutics Revenue by Countries (2014-2019) (Million US$)
    Table Rest of World Anti-Obesity Therapeutics Revenue Market Share by Countries (2014-2019)
    Figure Rest of World Anti-Obesity Therapeutics Revenue Market Share by Countries in 2019
    Figure Japan Anti-Obesity Therapeutics Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Anti-Obesity Therapeutics Revenue Growth Rate (2014-2019) (K Units)
    Figure Korea Anti-Obesity Therapeutics Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Anti-Obesity Therapeutics Revenue Growth Rate (2014-2019) (K Units)
    Figure India Anti-Obesity Therapeutics Sales Growth Rate (2014-2019) (K Units)
    Figure India Anti-Obesity Therapeutics Revenue Growth Rate (2014-2019) (K Units)
    Figure Southeast Asia Anti-Obesity Therapeutics Sales Growth Rate (2014-2019) (K Units)
    Figure Southeast Asia Anti-Obesity Therapeutics Revenue Growth Rate (2014-2019) (K Units)
    Table Bristol-Myers Squibb Company Details
    Table Bristol-Myers Squibb Description and Business Overview
    Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Bristol-Myers Squibb Recent Development
    Table Eisai Company Company Details
    Table Eisai Company Description and Business Overview
    Table Eisai Company Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Eisai Company Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Eisai Company Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Eisai Company Recent Development
    Table FlaxoSithKline plc. Company Details
    Table FlaxoSithKline plc. Description and Business Overview
    Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table FlaxoSithKline plc. Recent Development
    Table Novo Nordisk Company Details
    Table Novo Nordisk Description and Business Overview
    Table Novo Nordisk Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novo Nordisk Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Novo Nordisk Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Novo Nordisk Recent Development
    Table Alizyme Company Details
    Table Alizyme Description and Business Overview
    Table Alizyme Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Alizyme Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Alizyme Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Alizyme Recent Development
    Table BoehringerIngelheim GmbH Company Details
    Table BoehringerIngelheim GmbH Description and Business Overview
    Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table BoehringerIngelheim GmbH Recent Development
    Table Pfizer Company Details
    Table Pfizer Description and Business Overview
    Table Pfizer Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pfizer Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Pfizer Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Pfizer Recent Development
    Table Takeda Pharmaceutical Company Details
    Table Takeda Pharmaceutical Description and Business Overview
    Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Takeda Pharmaceutical Recent Development
    Table Rhythm Pharmaceuticals Company Details
    Table Rhythm Pharmaceuticals Description and Business Overview
    Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Rhythm Pharmaceuticals Recent Development
    Table Shionogi USA Company Details
    Table Shionogi USA Description and Business Overview
    Table Shionogi USA Anti-Obesity Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Shionogi USA Anti-Obesity Therapeutics Sales Growth Rate (2014-2019)
    Table Shionogi USA Anti-Obesity Therapeutics Sales Market Share in Global Market
    Table Shionogi USA Recent Development
    Table Vivus Company Details
    Table Zafgen Company Details
    Table Norgine Pharmaceuticals Ltd. Company Details
    Figure Anti-Obesity Therapeutics Value Chain
    Table Anti-Obesity Therapeutics Distributors List
    Table Anti-Obesity Therapeutics Customers List
    Table Global Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units) & (Million US$)
    Figure Global Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Table Global Anti-Obesity Therapeutics Sales Forecast by Type 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Forecast by Type 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Market Share Forecast by Type 2019-2025
    Table Global Anti-Obesity Therapeutics Sales Forecast by Application 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Forecast by Application 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Market Share Forecast by Application 2019-2025
    Table Global Anti-Obesity Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Sales Market Share Forecast by Regions 2019-2025
    Table Global Anti-Obesity Therapeutics Revenue Forecast by Regions 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Revenue Forecast by Regions 2019-2025 (K Units)
    Figure Global Anti-Obesity Therapeutics Revenue Market Share Forecast by Regions 2019-2025
    Figure United States Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure United States Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure European Union Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure European Union Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure China Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure China Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure Japan Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure Japan Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure Korea Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure Korea Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure India Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure India Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Figure Southeast Asia Anti-Obesity Therapeutics Sales Forecast 2019-2025 (K Units)
    Figure Southeast Asia Anti-Obesity Therapeutics Revenue Forecast 2019-2025 (Million US$)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3280

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4920

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6560

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions